Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 2
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Strength of immune selection in tumors varies with sex and age.
Castro A, Pyke RM, Zhang X, Thompson WK, Day CP, Alexandrov LB, Zanetti M, Carter H. Castro A, et al. Among authors: pyke rm. Nat Commun. 2020 Aug 17;11(1):4128. doi: 10.1038/s41467-020-17981-0. Nat Commun. 2020. PMID: 32807809 Free PMC article.
MHC-I genotype and tumor mutational burden predict response to immunotherapy.
Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R. Goodman AM, et al. Among authors: pyke rm. Genome Med. 2020 May 19;12(1):45. doi: 10.1186/s13073-020-00743-4. Genome Med. 2020. PMID: 32430031 Free PMC article.
Integrative genomic analysis of mouse and human hepatocellular carcinoma.
Dow M, Pyke RM, Tsui BY, Alexandrov LB, Nakagawa H, Taniguchi K, Seki E, Harismendy O, Shalapour S, Karin M, Carter H, Font-Burgada J. Dow M, et al. Among authors: pyke rm. Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):E9879-E9888. doi: 10.1073/pnas.1811029115. Epub 2018 Oct 4. Proc Natl Acad Sci U S A. 2018. PMID: 30287485 Free PMC article.
Withdrawal of 'Precision Neoantigen Discovery Using Large-scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation'.
Pyke RM, Mellacheruvu D, Dea S, Abbott CW, Zhang SV, Phillips NA, Harris J, Bartha G, Desai S, McClory R, West J, Snyder MP, Chen R, Boyle SM. Pyke RM, et al. Mol Cell Proteomics. 2023 Apr;22(4):100511. doi: 10.1016/j.mcpro.2023.100511. Epub 2023 Apr 3. Mol Cell Proteomics. 2023. PMID: 37019059 Free PMC article. No abstract available.
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance Mechanisms.
Abbott CW, Boyle SM, Pyke RM, McDaniel LD, Levy E, Navarro FCP, Mellacheruvu D, Zhang SV, Tan M, Santiago R, Rusan ZM, Milani P, Bartha G, Harris J, McClory R, Snyder MP, Jang S, Chen R. Abbott CW, et al. Among authors: pyke rm. Clin Cancer Res. 2021 Aug 1;27(15):4265-4276. doi: 10.1158/1078-0432.CCR-20-4314. Clin Cancer Res. 2021. PMID: 34341053 Free PMC article.
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Northcott J, Bartha G, Harris J, Li C, Navarro FCP, Pyke RM, Hong M, Zhang Q, Ma S, Chen TX, Lai J, Udar N, Saldivar JS, Ayash E, Anderson J, Li J, Cui T, Le T, Chow R, Velasco RJ, Mallo C, Santiago R, Bruce RC, Goodman LJ, Chen Y, Norton D, Chen RO, Lyle JM. Northcott J, et al. Among authors: pyke rm. Oncotarget. 2024 Mar 14;15:200-218. doi: 10.18632/oncotarget.28565. Oncotarget. 2024. PMID: 38484152 Free PMC article.
11 results